Relmada Therapeutics, Inc. (RLMD) Balance Sheet
RLMD balance sheet, 2025
December 31, 2025 · U.S. dollars$94.0M assets = $7.5M liabilities + $86.5M equity
Both columns are drawn to the same scale: what RLMD owns equals what it owes plus shareholders’ equity. Hover a block for its value.
RLMD financial health
Descriptive bands, not a rating. Fiscal 2025.
RLMD balance sheet trends, 2016–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $10.2M2016 | $94.0M2025 | +27.9%/yr | |
| Total liabilities | $3.2M2016 | $7.5M2025 | +9.9%/yr | |
| Shareholders’ equity | $7.0M2016 | $86.5M2025 | +32.1%/yr | |
| Cash & short-term investments | $8.5M2016 | $93.0M2025 | +30.5%/yr | |
| Total debt | $273,6702016 | $110,2472019 | −26.1%/yr | |
| Net cash (debt) | $8.2M2016 | $116.3M2019 | +$108.1M | |
| Working capital | $6.2M2016 | $87.6M2025 | +$81.3M | |
| Book value per share | $4.742022 | $2.192025 | −22.7%/yr | |
| Debt / equity | 0.042016 | 0.002019 | −0.04 | |
| Shares outstanding | 29.6M2022 | 39.5M2025 | +10.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
RLMD assets
RLMD liabilities and equity
RLMD debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
RLMD balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & short-term investments | $93.0M | $44.9M | $96.3M | $148.3M | $211.9M | $117.1M | $116.4M | $2.2M | $1.7M | $8.5M |
| Cash & equivalents | $3.5M | $3.9M | $4.1M | $5.4M | $44.4M | $2.5M | $36.3M | $2.2M | $1.7M | $8.5M |
| Short-term investments | $89.5M | $41.1M | $92.2M | $142.9M | $167.5M | $114.6M | $80.2M | — | — | — |
| Receivables | $0 | $0 | $0 | $512,432 | $86,377 | $79,457 | $73,091 | $72,103 | $291,916 | $263,342 |
| Inventory | $0 | $0 | $0 | $4.0M | $11.3M | $903,200 | $459,000 | $426,900 | $472,500 | $534,800 |
| Other current assets | $977,721 | $886,461 | $1.2M | $0 | $35 | $0 | $0 | $21 | $0 | $0 |
| Total current assets | $94.0M | $45.8M | $97.5M | $152.9M | $223.3M | $118.1M | $116.9M | $2.7M | $2.5M | $9.3M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $1,258 | $5,010 | $12,080 | $2,315 | $531,348 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $337,730 |
| Other non-current assets | $19,500 | $21,975 | $43,125 | $34,875 | $28,293 | $111,377 | $190,990 | $298,032 | $359,691 | $76,625 |
| Total assets | $94.0M | $45.8M | $97.6M | $152.9M | $223.3M | $118.2M | $117.1M | $3.0M | $2.8M | $10.2M |
| Liabilities | ||||||||||
| Accounts payable | $1.6M | $4.1M | $3.5M | $5.3M | $11.2M | $8.3M | $522,663 | $765,439 | $529,558 | $1.3M |
| Short-term debt | — | — | — | — | — | — | $110,247 | $285,170 | $276,670 | $273,670 |
| Deferred revenue | — | — | — | — | — | — | $1.3M | $659,500 | $394,600 | $634,900 |
| Total current liabilities | $6.4M | $10.3M | $12.2M | $12.5M | $15.1M | $12.6M | $1.5M | $5.9M | $1.4M | $3.1M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $2.7M | $0 |
| Other long-term liabilities | $1.1M | $4,467 | $0 | $123 | $75 | $542 | $1.3M | $2.7M | $0 | $140,914 |
| Total liabilities | $7.5M | $10.3M | $12.2M | $12.5M | $15.1M | $12.6M | $1.5M | $8.6M | $1.4M | $3.2M |
| Shareholders' equity | ||||||||||
| Common stock & paid-in capital | $73,333 | $30,174 | $30,099 | $30,099 | $27,740 | $16,333 | $14,457 | $3,137 | $12,528 | $12,035 |
| Retained earnings (deficit) | −$698.3M | −$640.9M | −$560.9M | −$462.1M | −$305.1M | −$179.3M | −$119.9M | −$94.3M | −$85.4M | −$79.1M |
| Accumulated other comprehensive income | — | — | — | $0 | — | $0 | $0 | $0 | −$4,600 | −$2,000 |
| Total shareholders' equity | $86.5M | $35.5M | $85.4M | $140.4M | $208.3M | $105.6M | $115.7M | −$5.5M | $1.5M | $7.0M |
| Key figures | ||||||||||
| Total debt | — | — | — | — | — | — | $110,247 | $2.9M | $2.9M | $273,670 |
| Net cash (debt) | — | — | — | — | — | — | $116.3M | −$702,684 | −$1.2M | $8.2M |
| Working capital | $87.6M | $35.5M | $85.3M | $140.4M | $208.2M | $105.5M | $115.5M | −$3.2M | $1.1M | $6.2M |
| Tangible book value | $86.5M | $35.5M | $85.4M | $140.4M | $208.3M | $105.6M | $115.7M | −$5.5M | $1.5M | $7.0M |
| Book value per share | $2.19 | $1.18 | $2.84 | $4.74 | — | — | — | — | — | — |
| Shares outstanding | 39.5M | 30.2M | 30.1M | 29.6M | — | — | — | — | — | — |
| Current ratio | 14.62 | 4.45 | 8.00 | 12.26 | 14.83 | 9.37 | 80.21 | 0.46 | 1.80 | 3.04 |
| Quick ratio | 14.46 | 4.36 | 7.90 | 11.94 | 14.08 | 9.30 | 79.92 | 0.39 | 1.45 | 2.86 |
| Debt / equity | — | — | — | — | — | — | 0.00 | — | 2.01 | 0.04 |
| Equity / assets | 92.0% | 77.5% | 87.5% | 91.8% | 93.3% | 89.3% | 98.8% | −180.9% | 51.5% | 68.7% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & short-term investments | $217.7M | $234.0M | $93.0M | $13.9M | $20.6M | $27.1M | $44.9M | $54.1M | $70.4M | $83.6M | $96.3M | $106.3M |
| Cash & equivalents | $11.3M | $9.8M | $3.5M | $1.4M | $1.4M | $1.1M | $3.9M | $1.5M | $2.1M | $1.3M | $4.1M | $6.7M |
| Short-term investments | $206.4M | $224.2M | $89.5M | $12.5M | $19.3M | $25.9M | $41.1M | $52.6M | $68.4M | $82.3M | $92.2M | $99.6M |
| Receivables | $10,912 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other current assets | $1.3M | $1.4M | $977,721 | $967,745 | $474,628 | $596,410 | $886,461 | $1.6M | $537,522 | $752,334 | $1.2M | $2.8M |
| Total current assets | $219.0M | $235.3M | $94.0M | $14.9M | $21.1M | $27.7M | $45.8M | $55.7M | $71.0M | $84.4M | $97.5M | $109.1M |
| Property, plant & equipment (net) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Goodwill & intangible assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-term investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other non-current assets | $19,500 | $19,500 | $19,500 | $21,975 | $21,975 | $21,975 | $21,975 | $21,975 | $53,625 | $43,125 | $43,125 | $47,715 |
| Total assets | $219.1M | $235.4M | $94.0M | $14.9M | $21.1M | $27.7M | $45.8M | $55.7M | $71.0M | $84.4M | $97.6M | $109.1M |
| Liabilities | ||||||||||||
| Accounts payable | $2.4M | $5.7M | $1.6M | $1.5M | $1.4M | $1.3M | $4.1M | $2.3M | $4.2M | $5.2M | $3.5M | $2.9M |
| Total current liabilities | $7.4M | $12.9M | $6.4M | $5.2M | $5.1M | $5.2M | $10.3M | $8.1M | $9.5M | $12.4M | $12.2M | $8.4M |
| Long-term debt | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other long-term liabilities | $5.1M | $3.7M | $1.1M | $221,106 | $32,116 | $7,505 | $4,467 | $12,562 | $0 | $0 | $0 | $0 |
| Total liabilities | $12.5M | $16.6M | $7.5M | $5.4M | $5.2M | $5.2M | $10.3M | $8.1M | $9.5M | $12.4M | $12.2M | $8.4M |
| Shareholders' equity | ||||||||||||
| Common stock & paid-in capital | $106,670 | $104,890 | $73,333 | $33,191 | $33,191 | $33,191 | $30,174 | $30,174 | $30,174 | $30,174 | $30,099 | $30,099 |
| Retained earnings (deficit) | −$730.2M | −$717.3M | −$698.3M | −$678.4M | −$668.3M | −$658.4M | −$640.9M | −$622.2M | −$600.5M | −$582.7M | −$560.9M | −$535.7M |
| Total shareholders' equity | $206.6M | $218.7M | $86.5M | $9.5M | $15.9M | $22.4M | $35.5M | $47.6M | $61.5M | $72.0M | $85.4M | $100.7M |
| Key figures | ||||||||||||
| Working capital | $211.6M | $222.5M | $87.6M | $9.7M | $16.0M | $22.4M | $35.5M | $47.6M | $61.4M | $72.0M | $85.3M | $100.7M |
| Tangible book value | $206.6M | $218.7M | $86.5M | $9.5M | $15.9M | $22.4M | $35.5M | $47.6M | $61.5M | $72.0M | $85.4M | $100.7M |
| Book value per share | $1.84 | $2.53 | $1.27 | $0.29 | $0.48 | $0.74 | $1.18 | $1.58 | $2.04 | $2.39 | $2.84 | $3.35 |
| Shares outstanding | 112.4M | 86.6M | 68.3M | 33.2M | 33.2M | 30.4M | 30.2M | 30.2M | 30.2M | 30.1M | 30.1M | 30.1M |
| Current ratio | 29.52 | 18.26 | 14.62 | 2.86 | 4.11 | 5.29 | 4.45 | 6.89 | 7.44 | 6.82 | 8.00 | 12.95 |
| Quick ratio | 29.34 | 18.15 | 14.46 | 2.68 | 4.02 | 5.17 | 4.36 | 6.69 | 7.39 | 6.76 | 7.90 | 12.62 |
| Equity / assets | 94.3% | 92.9% | 92.0% | 63.6% | 75.5% | 81.1% | 77.5% | 85.5% | 86.6% | 85.4% | 87.5% | 92.3% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed March 19, 2026); data from EODHD.
RLMD financial position
At the end of fiscal 2025 (December 31, 2025), Relmada Therapeutics had total assets of $94.0 million (up 105.2% from a year earlier), total liabilities of $7.5 million and shareholders' equity of $86.5 million. Its current ratio was 14.62. In the latest quarter (ended June 30, 2026) total assets were $219.1 million and equity $206.6 million.
Related: RLMD income statement, RLMD cash flow statement, RLMD key metrics. See the RLMD stock overview for the latest quote and news.
RLMD balance sheet FAQ
What are Relmada Therapeutics's total assets?
Relmada Therapeutics reported total assets of $94.0 million at the end of fiscal 2025 (December 31, 2025), compared with $45.8 million a year earlier.
How much cash does Relmada Therapeutics have?
Relmada Therapeutics held $93.0 million in cash and short-term investments at the end of fiscal 2025.
What is Relmada Therapeutics's book value?
Relmada Therapeutics's shareholders' equity (book value) was $86.5 million at the end of fiscal 2025, or $2.19 per share.
What is Relmada Therapeutics's current ratio?
Relmada Therapeutics had current assets of $94.0 million and current liabilities of $6.4 million, a current ratio of 14.62 (it can cover its short-term obligations).